EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Future of Uremic Toxin Management

Raymond Vanholder iD, Evelien Snauwaert iD, Francis Verbeke iD, Griet Glorieux iD

Toxins · 2024

DOI: 10.3390/toxins16110463 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, 2024. Verfasst von Raymond Vanholder und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, 9000 Gent, Belgium. Hauptthemen laut MEDLINE: Uremia, Renal Insufficiency, Chronic, Uremic Toxins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the progression of chronic kidney disease (CKD), the retention of uremic toxins plays a key role in the development of uremic syndrome. Knowledge about the nature and biological impact of uremic toxins has grown exponentially over the past decades. However, the science on reducing the concentration and effects of uremic toxins has not advanced in parallel. Additionally, the focus has remained for too long on dialysis strategies, which only benefit the small fraction of people with CKD who suffer from advanced kidney disease, whereas uremic toxicity effects are only partially prevented. This article reviews recent research on alternative methods to counteract uremic toxicity, emphasizing options that are also beneficial in the earlier stages of CKD, with a focus on both established methods and approaches which are still under investigation or at the experimental stage. We will consequently discuss the preservation of kidney function, the prevention of cardiovascular damage, gastro-intestinal interventions, including diet and biotics, and pharmacologic interventions. In the final part, we also review alternative options for extracorporeal uremic toxin removal. The future will reveal which of these options are valid for further development and evidence-based assessment, hopefully leading to a more sustainable treatment model for CKD than the current one.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UremiaRenal Insufficiency, ChronicUremic ToxinsHumansAnimalsRenal Dialysis

Stichwörter der Autor:innen

CKD progression preventionanti-fibrosisanti-inflammatory treatmentsbioticscardiovascular disease in CKDdialysisdietinflammationsenolyticstoxin removaluremic toxins

Substanzen

Uremic Toxins

Autor:innen und Institutionen

  • Nephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, 9000 Gent, Belgium.
  • Pediatric Nephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, 9000 Ghent, Belgium.
  • European Reference Network for Rare Kidney Diseases (ERKNet).

ORCID-Profile: Raymond Vanholder, Evelien Snauwaert, Francis Verbeke, Griet Glorieux

Zitieren

APA

Vanholder, R., Snauwaert, E., Verbeke, F., & Glorieux, G. (2024). Future of Uremic Toxin Management. Toxins. https://doi.org/10.3390/toxins16110463

Vancouver

Vanholder R, Snauwaert E, Verbeke F, Glorieux G. Future of Uremic Toxin Management. Toxins. 2024. doi:10.3390/toxins16110463

BibTeX
@article{Vanholder2024,
  author = {Vanholder, Raymond and Snauwaert, Evelien and Verbeke, Francis and Glorieux, Griet},
  title = {Future of Uremic Toxin Management},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16110463}
}
Kostenlos starten →